Relief Therapeutics Holding AG/ CH1251125998 /
| 2024-10-11 12:06:50 PM | Chg. -1.25 | Volume | Bid5:43:34 PM | Ask3:28:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.99CHF | -20.03% | 1,634 Turnover: 8,793.43 |
-Bid Size: - | -Ask Size: - | 60.66 mill.CHF | - | - |
GlobeNewswire
2023-12-20
Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline R...
GlobeNewswire
2022-03-07
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilit...
GlobeNewswire
2022-03-02
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-01-27
Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upco...
GlobeNewswire
2021-11-19
Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-10-26
Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-...
GlobeNewswire
2021-10-07
Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Form...
GlobeNewswire
2021-10-06
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application...
GlobeNewswire
2021-08-09
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. ...
GlobeNewswire
2021-05-25
Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
GlobeNewswire
2021-05-17
Acer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-03-22
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and ...
GlobeNewswire
2021-03-01
Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate...
GlobeNewswire
2021-01-25
Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Colla...
GlobeNewswire
2020-07-16
NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2...
GlobeNewswire
2020-06-24
NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Avipt...
GlobeNewswire
2020-06-11
Relief Therapeutics and NeuroRx Expand Clinical Trial Evaluating RLF-100 in Critically Ill COVID-19 ...
GlobeNewswire
2020-06-08
Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to All Patients with Critical COVID...
GlobeNewswire
2020-06-01
Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Cli...
